M4MM
CMS Finalizes Rule for Medicare CBD Coverage Pilot
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) has finalized regulations enabling a pilot program for federal health insurance coverage of hemp-derived CBD products, according to a recent statement from an executive at ...
Missouri Cannabis Sales Hit Record $1.5B in 2025
JEFFERSON CITY – Missouri's regulated Cannabis market posted its strongest year yet in 2025, with retailers recording approximately $1.5 billion in total sales, according to figures from the Missouri Department of Health and Senior Services. ...
New Hampshire House Advances Bill to Regulate Medical Psilocybin Use
CONCORD – The New Hampshire House of Representatives has given initial approval to a bipartisan measure that would establish a state program allowing supervised therapeutic access to psilocybin for qualifying medical conditions. House Bill 1809, ...
Trulieve Secures $140M in Senior Notes
TALLAHASSEE – Trulieve Cannabis Corp. wrapped up a $140 million private placement of 10.5% senior secured notes, tapping into robust investor appetite to fuel its operational push. The deal, upsized from initial plans, comes just ...
🚨🚨 BREAKING: TRUMP RESCHEDULES CANNABIS 🚨🚨
WASHINGTON, D.C. –After months of speculation, President Trump Issues Executive Order Directing Federal Rescheduling of Cannabis to Schedule III President Donald Trump has signed an executive order directing federal agencies to complete the rescheduling of ...
Czech Republic Approves Psilocybin Therapy Guidelines for 2026
PRAGUE – The Czech Republic has taken a measured step toward integrating psychedelic-assisted therapy into its healthcare system, approving detailed rules that will permit the controlled use of psilocybin for select patients beginning in January ...
MSOS ETF Rally Hints at Bigger Gains Ahead, Zuanic Report Finds
LOS ANGELES – A recent report from equity research firm Zuanic & Associates outlines substantial financial gains for U.S. MSOs if federal regulators shift Cannabis to Schedule III status, with savings potentially exceeding hundreds of ...
CMS Finalizes Rule for Medicare CBD Coverage Pilot
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) has finalized regulations enabling a pilot program for federal health insurance coverage of hemp-derived CBD products, according to a recent statement from an executive at ...
Missouri Cannabis Sales Hit Record $1.5B in 2025
JEFFERSON CITY – Missouri's regulated Cannabis market posted its strongest year yet in 2025, with retailers recording approximately $1.5 billion in total sales, according to figures from the Missouri Department of Health and Senior Services. ...
New Hampshire House Advances Bill to Regulate Medical Psilocybin Use
CONCORD – The New Hampshire House of Representatives has given initial approval to a bipartisan measure that would establish a state program allowing supervised therapeutic access to psilocybin for qualifying medical conditions. House Bill 1809, ...
California Pulls Cannabis Products from Shelves Due to Pesticide Concerns
LOS ANGELES- California this week ordered product recalls for five licensed cannabis products, including four vape pens and a vape cartridge, due to contamination with chlorfenapyr, a banned pesticide. These products, sold by West Coast ...
Evolving Hemp Regulations and Market Dynamics in Louisiana
LOS ANGELES- The hemp market is undergoing significant changes as new regulations affect how products are manufactured, sold, and consumed. The legal landscape shapes the future of hemp-derived products, necessitating staying updated on industry trends ...
Pesticide Scandal & Product Recalls Rocks California’s Cannabis Industry
LOS ANGELES--California's cannabis industry is reeling from a recent pesticide scandal that has undermined consumer confidence and highlighted regulatory shortcomings. An investigation by the Los Angeles Times, in collaboration with WeedWeek, revealed alarming levels of ...
The Demise of Chevron Deference: A New Era for Government Regulation and Its Impact on the Cannabis Industry
WASHINGTON, D.C. - In a landmark ruling, the Supreme Court has overturned a 40-year-old precedent known as "Chevron deference," which mandated that courts defer to the interpretations of federal agencies when a law is ambiguous, ...
Majority of North Dakota Voters Oppose Recreational Cannabis Legalization
LOS ANGELES- A recent poll commissioned by the Brighter Future Alliance and conducted by Public Opinion Strategies revealed that 57% of likely North Dakota voters are against the legalization of recreational cannabis for adults over ...
IRS Reaffirms Cannabis as Schedule I Substance; Section 280E Still Applies
WASHINGTON — The Internal Revenue Service (IRS) has issued a reminder that cannabis remains classified as a Schedule I controlled substance and is subject to the limitations of Internal Revenue Code Section 280E until any ...
Growing Interest in Microdosing Among Americans
LOS ANGELES- Americans are increasingly curious about microdosing, a practice involving minimal consumption of psychedelics or cannabis over extended periods, according to a study by the University of California San Diego published in JAMA Health ...
IRS Reaffirms Enforcement of Section 280E Amid Cannabis Industry Pushback
MIAMI, Florida--In a recent announcement, the Internal Revenue Service (IRS) underscored the ongoing enforcement of Internal Revenue Code Section 280E, a tax code provision that has long been a contentious issue for cannabis businesses. The ...
Cronos Group Secures $51 Million Credit Line
LOS ANGELES- Cronos Group's $51 million credit line will enhance production and facilitate global market expansion, positioning the company as a key player in the burgeoning cannabis industry. Canada’s Cronos Group has announced that it ...
Incannex Healthcare Receives FDA Approval for Phase 2 Clinical Trial of Psilocybin Therapy
LOS ANGELES- Incannex Healthcare Inc. a clinical-stage pharmaceutical company, has received approval from the US Food and Drug Administration (FDA) to commence a Phase 2 clinical trial for its psilocybin pharmaceutical formulation, PSX-001, in combination ...
Week’s In Review: Tilray Expands U.S. Presence with Acquisition of Four Molson Coors Craft Breweries; California Seizes Over $120 Million in Illegal Cannabis Since January; North Dakota Voters to Decide on Cannabis Legalization for Third Time
LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's ...
Week In Review: DEA’s Proposed Rescheduling of Cannabis Sparks Public Response; The Battle Over Recreational Cannabis Legalization Heats Up; Harris-Walz Ticket First to Support Federal Cannabis Legalization
LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's ...
Week In Review: Ohio Comes On Line; Texas Cities Advance Cannabis Decriminalization Efforts; Tilray Expands in Portugal; Philippine Lawmakers Push for Medical Cannabis Legalization
LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's ...
Week In Review: Dallas Officials Approve Cannabis Decriminalization Petition for November Ballot; Field Trip Health Ltd. Shares Rise 5.8% Amid Increased Trading Volume; SNDL Announces Major Restructuring to Save $20 Million Annually; Verano buys Cannabists Businesses
LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's ...
Week In Review: GOP-Led House Committee Approves Spending Bill Blocking Cannabis Rescheduling; Canopy Growth Corporation Stock Performance and Upcoming Earnings Report
LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's ...
